$42.51
0.571.36%
At close: Nov 17, 4:00 PM EST
$42.15
-0.36-0.85%
After Hours: 5:35 PM EST
Comments
Loading...
Rigel Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:RIGL | Benzinga
Rigel Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 4
EPS
$1.460
Quarterly Revenue
$69.46M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$282.08M
Analyze the earnings history of Rigel Pharmaceuticals using advanced sorting and filters.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
RIGL | Rigel Pharmaceuticals | $0.70 | $0.85 | $1.46 | 71.76% | $55.31M | $61.76M | $69.46M | 12.47% | 11/04/2025 | |
RIGL | Rigel Pharmaceuticals | -$0.06 | $1.63 | $3.28 | 101.23% | $36.84M | $75.08M | $101.69M | 35.43% | 08/05/2025 | |
RIGL | Rigel Pharmaceuticals | -$0.50 | $0.09 | $0.63 | 600.00% | $29.53M | $43.87M | $53.30M | 21.50% | 05/06/2025 | |
RIGL | Rigel Pharmaceuticals | $0.04 | $0.55 | $0.80 | 45.45% | $35.79M | $57.59M | $57.60M | 0.01% | 03/04/2025 | |
RIGL | Rigel Pharmaceuticals | -$0.30 | $0.06 | $0.70 | 1066.67% | $28.13M | $41.93M | $55.31M | 31.90% | 11/07/2024 | |
RIGL | Rigel Pharmaceuticals | -$0.38 | -$0.29 | -$0.06 | 79.31% | $26.89M | $33.42M | $36.84M | 10.24% | 08/06/2024 | |
RIGL | Rigel Pharmaceuticals | -$0.80 | -$0.30 | -$0.50 | -66.67% | $26.07M | $31.28M | $29.53M | -5.58% | 05/07/2024 | |
RIGL | Rigel Pharmaceuticals | $0.10 | -$0.30 | $0.00 | 100.00% | $51.28M | $34.10M | $35.79M | 4.96% | 03/05/2024 | |
RIGL | Rigel Pharmaceuticals | -$1.10 | -$0.70 | -$0.30 | 57.14% | $22.41M | $27.20M | $28.13M | 3.43% | 11/07/2023 | |
RIGL | Rigel Pharmaceuticals | -$0.80 | -$0.80 | -$0.40 | 50.00% | $29.82M | $26.02M | $26.89M | 3.33% | 08/01/2023 | |
RIGL | Rigel Pharmaceuticals | -$1.60 | -$1.00 | -$0.80 | 20.00% | $16.73M | $24.07M | $26.07M | 8.31% | 05/02/2023 | |
RIGL | Rigel Pharmaceuticals | -$1.10 | -$1.10 | $0.10 | 109.09% | $20.41M | $27.97M | $51.28M | 83.33% | 03/07/2023 | |
RIGL | Rigel Pharmaceuticals | -$1.20 | -$1.30 | -$1.10 | 15.38% | $21.54M | $22.61M | $22.41M | -0.88% | 11/03/2022 | |
RIGL | Rigel Pharmaceuticals | -$0.80 | -$1.20 | -$0.80 | 33.33% | $26.27M | $23.65M | $29.82M | 26.08% | 08/02/2022 | |
RIGL | Rigel Pharmaceuticals | $2.20 | -$1.40 | -$1.60 | -14.29% | $81.02M | $17.54M | $16.73M | -4.59% | 05/03/2022 | |
RIGL | Rigel Pharmaceuticals | -$1.10 | -$1.30 | -$1.10 | 15.38% | $18.45M | $21.90M | $20.41M | -6.81% | 03/01/2022 | |
RIGL | Rigel Pharmaceuticals | -$0.80 | -$1.00 | -$1.20 | -20.00% | $18.39M | $23.56M | $21.54M | -8.56% | 11/02/2021 | |
RIGL | Rigel Pharmaceuticals | -$1.00 | -$1.10 | -$0.80 | 27.27% | $16.02M | $20.37M | $26.27M | 28.94% | 08/03/2021 | |
RIGL | Rigel Pharmaceuticals | $1.30 | — | $2.20 | — | $55.76M | $31.05M | $81.02M | 160.93% | 05/05/2021 | |
RIGL | Rigel Pharmaceuticals | -$1.00 | -$1.10 | -$1.10 | 0.00% | $15.40M | $18.10M | $18.45M | 1.93% | 03/02/2021 |
Rigel Pharmaceuticals (RIGL) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $1.46 | $0.85 | 71.8 % |
| Q2 | 2025-08-05 | $3.28 | $1.63 | 101.2 % |
| Q1 | 2025-05-06 | $0.63 | $0.09 | 600.0 % |
| Q4 | 2025-03-04 | $0.80 | $0.55 | 45.5 % |
Rigel Pharmaceuticals (RIGL) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $69.46M | $61.76M | 12.5 % |
| Q2 | 2025-08-05 | $101.69M | $75.08M | 35.4 % |
| Q1 | 2025-05-06 | $53.30M | $43.87M | 21.5 % |
| Q4 | 2025-03-04 | $57.60M | $57.59M | 0.01 % |
FAQ
When is Rigel Pharmaceuticals (NASDAQ:RIGL) reporting earnings?
Rigel Pharmaceuticals (RIGL) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 4, 2025 for Q3.
What were the latest earnings per share (EPS) for Rigel Pharmaceuticals (NASDAQ:RIGL)?
Rigel Pharmaceuticals (RIGL) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 4, 2025 for Q3 and the Actual EPS was $1.46, which beat the estimate of $0.85.
What were Rigel Pharmaceuticals’s (NASDAQ:RIGL) revenues?
Rigel Pharmaceuticals (RIGL) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 4, 2025 for Q3 and the Actual Revenue was $69.5M, which beat the estimate of $61.8M.
Browse earnings estimates, EPS, and revenue on all stocks.
